SEC Form 4 · accession 0001209191-18-044967
CAMBREX CORP · CBM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven M Klosk
Officer — President & CEO · Director
Period of report
Aug 1, 2018
Accepted (ET)
Aug 2, 2018 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000820081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 1, 2018 | M | 50,000 | $16.905 | A | 213,328 | D | |
| Common StockF1 | Aug 1, 2018 | M | 5,000 | $17.81 | A | 218,328 | D | |
| Common StockF1,F2 | Aug 1, 2018 | S | 32,218 | $62.2331 | D | 186,110 | D | |
| Common StockF1,F3 | Aug 1, 2018 | S | 22,782 | $62.7786 | D | 163,328 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $16.905 | Aug 1, 2018 | M | 50,000 | A | — | Oct 28, 2020 | Common Stock | 50,000 | 0 | D |
| Stock Option (right to buy)F5 | $17.81 | Aug 1, 2018 | M | 5,000 | A | — | Oct 22, 2021 | Common Stock | 5,000 | 75,000 | D |
Explanation of responses
- F1The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.70 to $62.675 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.70 to $62.95 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4.
- F4The option representing a right to purchase 80,000 shares became exercisable in four equal installments beginning October 28,2014, which was the first anniversary of the date on which the option was granted.
- F5The option representing a right to purchase 80,000 shares became exercisable in four equal installments beginning October 22,2015, which was the first anniversary of the date on which the option was granted.